Skip to main content
    Medicines Information Centre logo

Medicines Information Centre

  • Home
  • About us
    • MIC
    • HIV & TB Hotline
  • News
    • News Archive
  • Resources
    • Educational Material/Posters
    • Guidelines
    • SA HIV/TB Hotline App
  • Research
  • Training
  • Contact Us

Our study, published in JIAS

17 Mar 2022
17 Mar 2022

We are proud to announce that our paper, "South African healthcare workers’ knowledge of dolutegravir's drug–drug interactions in the first year of its rollout: a cross-sectional online survey", has been published in the Journal of the International AIDS Society.

Thank you to everyone who participated in the survey!

  • Latest
CAncer

Antiparasitics for cancer management

08 Apr 2026
Reuse medicine

New uses for existing medications

08 Apr 2026
cvd

Cumulative anticholinergic use and cardiovascular disease (CVD)

08 Apr 2026
Withdrawn

Specific factor Xa inhibitor reversal agent withdrawn in USA

27 Feb 2026
Adherence

Interesting insights into adherence vs disease control

27 Feb 2026
Vaccine

Important finding for future adenovirus vaccines

27 Feb 2026
Medicines Information Centre logo

Contact Us

Tel: +27 (0)21 406 6829

HIV & TB HCW Hotline: 0800 212 506 or 021 406 6782
Please Call Me/SMS: 071 840 1572

E-mail: pha-mic@uct.ac.za

The information shared on these pages is intended for use by health professionals. It has been compiled from information available to the National HIV & TB Health Care Worker Hotline based at the Medicines Information Centre, and although the greatest care has been taken, the Medicines Information Centre does not accept responsibility for errors or omissions.
  • Facebook
  • LinkedIn
Copyright © - 2026 - University of Cape Town - All rights reserved. POPIA | PAIA.